ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 53 filers reported holding ALIGOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $874,000 | -97.6% | 1,000,000 | -67.9% | 0.12% | -96.7% |
| Q4 2021 | $36,949,000 | +21.4% | 3,112,785 | +58.6% | 3.81% | +73.6% |
| Q3 2021 | $30,443,000 | +601.6% | 1,962,785 | +822.4% | 2.20% | +501.4% |
| Q2 2021 | $4,339,000 | -60.0% | 212,785 | -55.3% | 0.36% | -65.5% |
| Q1 2021 | $10,837,000 | -35.4% | 476,547 | -21.4% | 1.06% | -26.4% |
| Q4 2020 | $16,771,000 | – | 606,548 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $47,301,000 | 15.67% |
| Pivotal bioVenture Partners Investment Advisor LLC | 876,548 | $17,873,000 | 7.04% |
| Vivo Capital, LLC | 3,547,030 | $72,306,000 | 3.13% |
| Novo Holdings A/S | 2,614,563 | $53,311,000 | 2.36% |
| ACUTA CAPITAL PARTNERS, LLC | 214,254 | $4,368,000 | 1.75% |
| Boxer Capital, LLC | 1,526,048 | $31,108,000 | 1.10% |
| VR Adviser, LLC | 408,377 | $8,325,000 | 1.01% |
| Cormorant Asset Management, LP | 905,467 | $18,458,000 | 0.63% |
| HHLR ADVISORS, LTD. | 2,165,064 | $44,135,000 | 0.45% |
| Logos Global Management LP | 212,785 | $4,339,000 | 0.36% |